Perrigo Announces Commercial Launch Of Betamethasone FoamPerrigo Co. Tuesday announced that it has begun commercial shipments of betamethasone valerate foam 0.12%, the generic equivalent of Luxiq Foam, consistent with the date certain launch settlement previously announced.
Perrigo Announces FDA Final Approval Of Betamethasone Valerate FoamPerrigo Co. (Nasdaq: PRGO) Tuesday announced that its partner, Cobrek Pharmaceuticals Inc., received final approval from the United States Food and Drug Administration for its Abbreviated New Drug Application for betamethasone valerate foam 0.12 percent, the generic equivalent of Luxiq Foam.

More From CBS Detroit

Guide: Last Minute Valentine's Day IdeasYou've got less than a week to plan the most romantic night of the year. Better get going!
Best Places To Get A Hot Toddy
Best Sledding Hills

Watch & Listen